Systematic mediation and interaction analyses of kidney function genetic loci in a general population study

Dariush Ghasemi-Semeskandeh,David Emmert,Eva Koenig,Luisa Foco,Martin Gogele,Laura Barin,Ryosuke Fujii,Christian Fuchsberger,Dorien J.M. Peters,Peter P. Pramstaller,Cristian Pattaro

DOI: https://doi.org/10.1101/2023.04.15.23288540

2024-08-27

Abstract:Chronic kidney disease (CKD) is a complex disease affecting >10% of the global population, with large between- and within-continent variability reflecting major environmental effects. To identify molecular targets for treatment, genome-wide association study meta-analyses (GWAMAs) of CKD-defining traits have identified hundreds of genetic loci in aggregated populations. However, while GWAMAs estimate the average allelic effect across studies, single population studies may be relevant to unravel specific mechanisms. To assess whether an individual study from a specific population could extend existing knowledge on kidney function genetics, we selected 147 kidney function relevant loci identified by a large GWAMA, assessing their association with the glomerular filtration rate estimated from serum creatinine (eGFRcrea) in the Cooperative Health Research In South Tyrol (CHRIS) study (n=10,146), conducted in an Alpine region where thyroid dysfunction is common. We replicated associations with single nucleotide polymorphisms (SNPs) at 11 loci, showing up-to-5.4 times larger effect sizes than in the corresponding GWAMA, not explainable by minor allele frequency differences. Systematic mediation analysis across 70 quantitative traits identified serum magnesium and the activated partial thromboplastin time as partial mediators of the eGFRcrea associations at SHROOM3 and SLC34A1, respectively. Given that free triiodothyronine and thyroxine were effect modifiers across all loci, we conducted SNP-by-thyroid stimulating hormone (TSH) interaction analyses, identifying significant interactions at STC1: SNPs had larger effects on eGFRcrea at higher TSH levels, possibly reflecting stanniocalcin-1 autocrine and paracrine role. Individual population studies can help characterize genetic associations. The interplay between phenotypes at SHROOM3 and SLC34A1 and the role of thyroid function as a genetic effect modifier warrant further investigations.

Epidemiology

What problem does this paper attempt to address?

The problems that this paper attempts to solve are as follows: In a specific population sample, through systematic mediation and interaction analysis, evaluate whether the known genetic loci related to renal function can provide new insights into biological mechanisms, especially in a mountainous population where thyroid dysfunction is relatively common. Specifically, the researchers hope to understand:

1. **Genetic associations in specific populations**: In the Cooperative Health Research In South Tyrol (CHRIS) study, verify whether 147 known genetic loci related to renal function also have significant associations in this specific population, and whether the effect sizes of these loci are different in the specific population.

2. **Reasons for differences in effect sizes**: For those genetic loci that show larger effect sizes in the CHRIS study, the researchers hope to explore possible reasons through mediation analysis, that is, whether there are certain biochemical or physiological indicators as mediator variables that affect the relationship between these genetic loci and the estimated glomerular filtration rate (eGFRcrea).

3. **The influence of thyroid function**: Given the high incidence of thyroid dysfunction in the study area, the researchers also explored whether thyroid - function - related indicators (such as free triiodothyronine FT3 and thyroxine FT4) act as effect modifiers and affect the relationship between genetic loci and eGFRcrea.

Through these analyses, the researchers aim to reveal the characteristics of genetic associations in specific populations and how these characteristics are affected by environmental factors (such as thyroid dysfunction), thereby providing new clues for the discovery of molecular targets in chronic kidney disease (CKD).